Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Por um escritor misterioso
Descrição
BIRB 796 (Doramapimod) P38 MAPK inhibitor,cell permeable and
Structure-based design, synthesis and biological evaluation of N
Figure 1 from 'Reverse' alpha-ketoamide-based p38 MAP kinase
Novel strategies for inhibition of the p38 MAPK pathway: Trends in
Figure 1 from 'Reverse' alpha-ketoamide-based p38 MAP kinase
Current status and future prospects of p38α/MAPK14 kinase and its
Full article: A patent review of MAPK inhibitors (2018 – present)
Figure 1 from Switch control pocket inhibitors of p38-MAP kinase
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
de
por adulto (o preço varia de acordo com o tamanho do grupo)
